BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37813168)

  • 1. Exogenous recombinant N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) inhibits progression of B16F10 cutaneous melanomas and modulates cell signaling.
    Bhattacharyya S; O-Sullivan I; Tu J; Chen Z; Tobacman JK
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166913. PubMed ID: 37813168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decline in arylsulfatase B leads to increased invasiveness of melanoma cells.
    Bhattacharyya S; Feferman L; Terai K; Dudek AZ; Tobacman JK
    Oncotarget; 2017 Jan; 8(3):4169-4180. PubMed ID: 27926479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of chondroitin-4-sulfotransferase (CHST11) expression by opposing effects of arylsulfatase B on BMP4 and Wnt9A.
    Bhattacharyya S; Feferman L; Tobacman JK
    Biochim Biophys Acta; 2015 Mar; 1849(3):342-52. PubMed ID: 25511584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Phosphatase Activity Follows Decline in Sulfatase Activity and Leads to Transcriptional Effects through Sustained Phosphorylation of Transcription Factor MITF.
    Bhattacharyya S; Feferman L; Tobacman JK
    PLoS One; 2016; 11(4):e0153463. PubMed ID: 27078017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline in arylsulfatase B expression increases EGFR expression by inhibiting the protein-tyrosine phosphatase SHP2 and activating JNK in prostate cells.
    Bhattacharyya S; Feferman L; Han X; Ouyang Y; Zhang F; Linhardt RJ; Tobacman JK
    J Biol Chem; 2018 Jul; 293(28):11076-11087. PubMed ID: 29794138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of colonic Wnt9A through Sp1-mediated transcriptional effects involving arylsulfatase B, chondroitin 4-sulfate, and galectin-3.
    Bhattacharyya S; Feferman L; Tobacman JK
    J Biol Chem; 2014 Jun; 289(25):17564-75. PubMed ID: 24778176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of salt exposure on N-acetylgalactosamine-4-sulfatase (arylsulfatase B) activity, glycosaminoglycans, kininogen, and bradykinin.
    Kotlo K; Bhattacharyya S; Yang B; Feferman L; Tejaskumar S; Linhardt R; Danziger R; Tobacman JK
    Glycoconj J; 2013 Oct; 30(7):667-76. PubMed ID: 23385884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia reduces arylsulfatase B activity and silencing arylsulfatase B replicates and mediates the effects of hypoxia.
    Bhattacharyya S; Tobacman JK
    PLoS One; 2012; 7(3):e33250. PubMed ID: 22428001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arylsulfatase B regulates versican expression by galectin-3 and AP-1 mediated transcriptional effects.
    Bhattacharyya S; Feferman L; Tobacman JK
    Oncogene; 2014 Nov; 33(47):5467-76. PubMed ID: 24240681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profound Impact of Decline in N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on Molecular Pathophysiology and Human Diseases.
    Tobacman JK; Bhattacharyya S
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decline in arylsulfatase B and Increase in chondroitin 4-sulfotransferase combine to increase chondroitin 4-sulfate in traumatic brain injury.
    Bhattacharyya S; Zhang X; Feferman L; Johnson D; Tortella FC; Guizzetti M; Tobacman JK
    J Neurochem; 2015 Aug; 134(4):728-39. PubMed ID: 25943740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased CHST15 follows decline in arylsulfatase B (ARSB) and disinhibition of non-canonical WNT signaling: potential impact on epithelial and mesenchymal identity.
    Bhattacharyya S; Feferman L; Han X; Xia K; Zhang F; Linhardt RJ; Tobacman JK
    Oncotarget; 2020 Jun; 11(24):2327-2344. PubMed ID: 32595831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular signature of kappa-carrageenan mimics chondroitin-4-sulfate and dermatan sulfate and enables interaction with arylsulfatase B.
    Bhattacharyya S; Tobacman JK
    J Nutr Biochem; 2012 Sep; 23(9):1058-63. PubMed ID: 22079206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of estrogen exposure on arylsulfatase B, galactose-6-sulfatase, and steroid sulfatase in rat prostate development.
    Feferman L; Bhattacharyya S; Birch L; Prins GS; Tobacman JK
    J Steroid Biochem Mol Biol; 2014 Sep; 143():105-14. PubMed ID: 24508597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arylsulfatase B modulates neurite outgrowth via astrocyte chondroitin-4-sulfate: dysregulation by ethanol.
    Zhang X; Bhattacharyya S; Kusumo H; Goodlett CR; Tobacman JK; Guizzetti M
    Glia; 2014 Feb; 62(2):259-71. PubMed ID: 24311516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Cerebral Serum Amyloid A2 and Parameters of Oxidation in Arylsulfatase B (N-Acetylgalactosamine-4-Sulfatase)-Null Mice.
    Bhattacharyya S; Tobacman JK
    J Alzheimers Dis Rep; 2023; 7(1):527-534. PubMed ID: 37313486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arylsulfatase B (N-acetylgalactosamine-4-sulfatase): potential role as a biomarker in prostate cancer.
    Feferman L; Bhattacharyya S; Deaton R; Gann P; Guzman G; Kajdacsy-Balla A; Tobacman JK
    Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):277-84. PubMed ID: 23835622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 spike protein-ACE2 interaction increases carbohydrate sulfotransferases and reduces N-acetylgalactosamine-4-sulfatase by p38 MAPK.
    Bhattacharyya S; Tobacman JK
    Signal Transduct Target Ther; 2024 Feb; 9(1):39. PubMed ID: 38355690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Cerebral Serum Amyloid A2 and Parameters of Oxidation in Arylsulfatase B (N-Acetylgalactosamine-4-Sulfatase)-Null Mice.
    Bhattacharyya S; Tobacman JK
    bioRxiv; 2023 Apr; ():. PubMed ID: 37066366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in Chondroitin Sulfate and Decline in Arylsulfatase B May Contribute to Pathophysiology of COVID-19 Respiratory Failure.
    Tzankov A; Bhattacharyya S; Kotlo K; Tobacman JK
    Pathobiology; 2022; 89(2):81-91. PubMed ID: 34788765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.